COX-2 expression significantly correlated with tumor invasion depth and recurrence in BCC, highlighting its potential as a prognostic marker and therapeutic target, while SMA showed limited relevance to tumor behavior. The gene discussed is PTGS2; the disease is skin basal cell carcinoma.